Heilongjiang Haoyun Pharmaceutical Co., Ltd

Heilongjiang Haoyun Pharmaceutical Co., Ltd. was founded in 2006 and is a comprehensive joint-stock enterprise that integrates production, research and development, import and export trade. It is a national high-tech enterprise and has passed ISO9001:2015 quality management system certification, ISO14001:2015 environmental management system certification, and ISO45001:2018 occupational health and safety management system certification. The registered capital of the company is 26 million yuan, and the total assets are 430 million yuan. The production base is located in Anda City, Heilongjiang Province.
Mainly engaged in the production of pharmaceutical intermediates; Production of chemical, cosmetic intermediates, polyether ether ketone (PEEK) raw materials and pesticide additives; Research, development and production of fine chemical products and auxiliary materials required by electronics, military industry, nuclear industry, etc.
The company has obtained qualifications for special reactions such as chlorination reaction, cyanide reaction, bromination reaction, azide reaction, etc., and has mastered the special processes of ultra vacuum distillation (20-30Pa) and -100 degree reaction kettle.
The company adheres to the principle of taking enterprises as the main body, market-oriented, and relying on university research institutes, and has established long-term cooperative relationships with multiple well-known domestic universities and research institutes. Through pilot testing and production, the scientific research achievements developed by universities and research institutions are directly transformed into productivity, achieving industrial production.
The company focuses on specialized, refined, special, and new characteristic products, and the new project is motivated to fill the domestic gap. Committed to becoming a national key production base for Cephalosporin antibiotic intermediates, a production base for fluoride industry, a production base for isotope extraction, a production base for high-end condensing agent, and a production base for characteristic raw material drug intermediates, timely extending to the fields of pharmaceutical raw material drug production and formulation production.
The company will continue to promote the corporate spirit of "integrity based, customer first, quality first, and innovation oriented", and make due contributions to the continuous progress and harmonious development of human society!